Abstract:Objective. To identify disease-related genes and immune-regulatory pathways in the pathogenesis of systemic lupus erythematosus (SLE) by using gene expression profiling and protein-protein interaction analysis.Methods. Peripheral white blood cell gene expression profiles of 10 SLE patients were determined by oligonucleotide microarray analysis. Clustering of the gene expression profile was compared with the clinical immune phenotype. SLE-induced genes that were over- or under-expressed were determined and independently validated using a real-time polymerase chain reaction (PCR) method. To study their potential function and the possible pathways involved, a candidate gene was cloned and a GST (glutathione S-transferase) fusion protein was expressed in Escherichia coli. The fusion protein was further purified using the glutathione Sepharose 4B system, and was treated as bait to capture prey from SLE peripheral white blood cell lysate. MALDI-TOF (matrix-assisted laser desorption/ionization-time-of-flight) mass spectrometry was then performed to determine the prey protein.Results. Similarity was found between the gene expression profile and the immune phenotype clusters of the SLE patients. More than 20 disease-associated genes were identified, some of which have not been related to SLE previously. Of these genes, a cluster of interferon-induced genes were highly correlated. IFIT1 (interferon-induced with tetratricopeptide repeats 1) was one of these genes, and overexpression of its mRNA was confirmed independently by real-time PCR in a larger population (40 SLE patients and 29 normal controls). An IFIT1 protein- protein interaction study showed that IFIT1 may interact with Rho/Rac guanine nucleotide exchange factor.Conclusion. The gene expression profile seems to be the molecular basis of the diverse immune phenotype of SLE. On the basis of the SLE-related genes found in this study, we suggest that the interferon-related immune pathway is important in the pathogenesis of SLE. IFIT1 is the first gene described as a candidate gene for SLE, and may function by activating Rho proteins through interaction with Rho/Rac guanine nucleotide exchange factor. IFIT1 and the interferon-related pathway may provide potential targets for novel interventions in the treatment of SLE.

Roles of interferon induced protein with tetratricopeptide repeats (IFIT) family in autoimmune disease

Type I Interferons in the Pathogenesis and Treatment of Sjögren’s Syndrome: an Update

Dual role of interferons in tumor immunology

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity

The IFITM protein family in adaptive immunity

The multiple roles of interferon regulatory factor family in health and disease

Interferon Regulatory Factors: A Key to Tumour Immunity

Research Progress into the Biological Functions of IFITM3

Current Progress on Host Antiviral Factor IFITMs

Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer

Protein Interaction for an Interferon-Inducible Systemic Lupus Associated Gene, IFIT1

Interferons and autoimmune disorders

The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies

Regulating IRFs in IFN Driven Disease

IFN-Induced Protein with Tetratricopeptide Repeats 2 Limits Autoimmune Inflammation by Regulating Myeloid Cell Activation and Metabolic Activity

Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders

The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes

Progress of the interferon regulatory factors in the development of tumor

IFITM-Family Proteins: the Cell's First Line of Antiviral Defense

IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease